Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 6
2022 2
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes.
Wang Q, Sun N, Meixner R, Le Gleut R, Kunzke T, Feuchtinger A, Wang J, Shen J, Kircher S, Dischinger U, Weigand I, Beuschlein F, Fassnacht M, Kroiss M, Walch A. Wang Q, et al. Among authors: le gleut r. JCI Insight. 2023 Aug 22;8(16):e167007. doi: 10.1172/jci.insight.167007. JCI Insight. 2023. PMID: 37606037 Free PMC article.
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison.
Kroidl I, Winter S, Rubio-Acero R, Bakuli A, Geldmacher C, Eser TM, Déak F, Horn S, Zielke A, Ahmed MIM, Diepers P, Guggenbühl J, Frese J, Bruger J, Puchinger K, Reich J, Falk P, Markgraf A, Fensterseifer H, Paunovic I, Thomschke A, Pritsch M, Riess F, Saathoff E, Hoelscher M, Olbrich L, Castelletti N, Wieser A; KoCo19/ORCHESTRA Study Group. Kroidl I, et al. Virol J. 2023 Sep 1;20(1):200. doi: 10.1186/s12985-023-02167-z. Virol J. 2023. PMID: 37658454 Free PMC article.
Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection.
Nakayama M, Marchi H, Dmitrieva AM, Chakraborty A, Merl-Pham J, Hennen E, Le Gleut R, Ruppert C, Guenther A, Kahnert K, Behr J, Hilgendorff A, Hauck SM, Adler H, Staab-Weijnitz CA. Nakayama M, et al. Among authors: le gleut r. Front Microbiol. 2023 Jan 11;13:957830. doi: 10.3389/fmicb.2022.957830. eCollection 2022. Front Microbiol. 2023. PMID: 36713229 Free PMC article.
Integrative modelling of reported case numbers and seroprevalence reveals time-dependent test efficiency and infectious contacts.
Contento L, Castelletti N, Raimúndez E, Le Gleut R, Schälte Y, Stapor P, Hinske LC, Hoelscher M, Wieser A, Radon K, Fuchs C, Hasenauer J; KoCo19 study group. Contento L, et al. Among authors: le gleut r. Epidemics. 2023 Jun;43:100681. doi: 10.1016/j.epidem.2023.100681. Epub 2023 Mar 11. Epidemics. 2023. PMID: 36931114 Free PMC article.
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.
Pritsch M, Radon K, Bakuli A, Le Gleut R, Olbrich L, Guggenbüehl Noller JM, Saathoff E, Castelletti N, Garí M, Pütz P, Schälte Y, Frahnow T, Wölfel R, Rothe C, Pletschette M, Metaxa D, Forster F, Thiel V, Rieß F, Diefenbach MN, Fröschl G, Bruger J, Winter S, Frese J, Puchinger K, Brand I, Kroidl I, Hasenauer J, Fuchs C, Wieser A, Hoelscher M, On Behalf Of The KoCo Study Group. Pritsch M, et al. Among authors: le gleut r. Int J Environ Res Public Health. 2021 Mar 30;18(7):3572. doi: 10.3390/ijerph18073572. Int J Environ Res Public Health. 2021. PMID: 33808249 Free PMC article.
Socioeconomic and risk-related drivers of compliance with measures to prevent SARS-CoV-2 infection: evidence from the Munich-based KoCo19 study.
Pedron S, Laxy M, Radon K, Le Gleut R, Castelletti N, Noller JMG, Diefenbach MN, Hölscher M, Leidl R, Schwettmann L; KoCo19 collaboration group. Pedron S, et al. Among authors: le gleut r. BMC Public Health. 2023 May 11;23(1):860. doi: 10.1186/s12889-023-15759-9. BMC Public Health. 2023. PMID: 37170091 Free PMC article.
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant.
Le Gleut R, Plank M, Pütz P, Radon K, Bakuli A, Rubio-Acero R, Paunovic I, Rieß F, Winter S, Reinkemeyer C, Schälte Y, Olbrich L, Hannes M, Kroidl I, Noreña I, Janke C, Wieser A, Hoelscher M, Fuchs C, Castelletti N; KoCo19/ORCHESTRA-study group. Le Gleut R, et al. BMC Infect Dis. 2023 Jul 13;23(1):466. doi: 10.1186/s12879-023-08435-1. BMC Infect Dis. 2023. PMID: 37442952 Free PMC article.
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers.
Reinkemeyer C, Khazaei Y, Weigert M, Hannes M, Le Gleut R, Plank M, Winter S, Noreña I, Meier T, Xu L, Rubio-Acero R, Wiegrebe S, Le Thi TG, Fuchs C, Radon K, Paunovic I, Janke C, Wieser A, Küchenhoff H, Hoelscher M, Castelletti N; KoCo-Impf/ORCHESTRA working group. Reinkemeyer C, et al. Among authors: le gleut r. Viruses. 2023 Jul 18;15(7):1574. doi: 10.3390/v15071574. Viruses. 2023. PMID: 37515259 Free PMC article.
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2.
Olbrich L, Castelletti N, Schälte Y, Garí M, Pütz P, Bakuli A, Pritsch M, Kroidl I, Saathoff E, Guggenbuehl Noller JM, Fingerle V, Le Gleut R, Gilberg L, Brand I, Falk P, Markgraf A, Deák F, Riess F, Diefenbach M, Eser T, Weinauer F, Martin S, Quenzel EM, Becker M, Durner J, Girl P, Müller K, Radon K, Fuchs C, Wölfel R, Hasenauer J, Hoelscher M, Wieser A, On Behalf Of The KoCo-Study Group. Olbrich L, et al. Among authors: le gleut r. J Gen Virol. 2021 Oct;102(10):001653. doi: 10.1099/jgv.0.001653. J Gen Virol. 2021. PMID: 34623233 Free PMC article.
16 results